Our doctors are recognized experts in caring for people with amyotrophic lateral sclerosis. We have made significant contributions to the body of research into this difficult disease.
Our program takes a comprehensive approach to treatment that includes:
Multispecialty team approach that brings together doctors; physical, occupational, speech and respiratory therapists; a genetic counselor; and other professionals in the same clinic to consult about your condition.
Novel therapies, as well as conventional treatment with medication, such as Rilutek® (riluzole), to slow the progression of the disease.
Investigative therapies, including clinical trials of medications and devices aimed at managing ALS symptoms.
Specific treatment for ALS will be determined by your doctor based on:
Your age, overall health, and medical history
Extent of the disease
Your tolerance for specific medications, procedures, or therapies
Our Stanford researchers are participating in research studies to increase their understanding of genes that may cause the disease, mechanisms that can trigger motor neurons to degenerate in ALS, and approaches to stop the progress leading to cell death.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.